Life Extension Blood Test Super Sale

Life Extension Magazine

LE Magazine August 2005

Super Oxide Dismutase (SOD)

Boosting your body’s store of the enzyme SOD provides powerful protection against oxidative stress. By John Colman


Free radicals and oxidative stress are associated with accelerated aging and the onset of degenerative diseases. Internally generated anti-oxidants help protect against the effects of oxidative stress.

One of the most important antioxidant enzymes in humans is superoxide dismutase (SOD). Numerous studies correlate diminished SOD levels with disease, suggesting that abundant SOD promotes longer life. Two supplements in particular—SODzyme™ and GliSODin®—have been shown to boost levels of SOD and other antioxidant enzymes. SODzyme™ and GliSODin® offer promise in slowing aging, promoting longevity, relieving pain, modulating inflammation, and quenching free radicals. These powerful compounds may thus help promote good health and protect against many of the degenerative conditions associated with aging.

Editor’s note: People who are allergic to wheat, soy, corn, or gluten should consult their physician before using products containing SODzyme™ or GliSODin®.


1. Knight JA. Free radicals: their history and current status in aging and disease. Ann Clin Lab Sci. 1998 Nov-Dec; 28(6):331-46.

2. Reedy EA. The discovery of retrolental fibroplasia and the role of oxygen: a historical review, 1942-1956. Neonatal Netw. 2004 Mar;23(2):31-8.

3. Huang H, Manton KG. The role of oxidative damage in mitochondria during aging: a review. Front Biosci. 2004 May 1;91100-17.

4. Inoue M, Sato EF, Nishikawa M, et al. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem. 2003 Dec;10(23):2495-505.

5. Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. 2003 Mar;131(3):398-404.

6. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med. 2000 Feb 1;28(3):463-99.

7. Kashiwagi K, Shinkai T, Kajii E, Kashiwagi A. The effects of reactive oxygen species on amphibian aging. Comp Biochem Physiol C Toxicol Pharmacol. 2005 Feb;140(2):197-205.

8. Lishnevskaia VL. The role of free radicals oxidation in the deterioration of haemovascular homeostasis in aging. Adv Gerontol. 2004;13:52-7.

9. Karatas F, Ozates I, Canatan H, et al. Antioxidant status & lipid peroxidation in patients with rheumatoid arthritis. Indian J Med Res. 2003 Oct;118:178-81.

10. Mazzetti I, Grigolo B, Pulsatelli L, et al. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci (Lond). 2001 Dec;101(6):593-9.

11. Bagis S, Tamer L, Sahin G, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int. 2005 Apr;25(3):188-90.

12.Abou-Seif MA, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta. 2004 Aug 16;346(2):161-70.

13. Cai Q, Shu XO, Wen W, et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res. 2004;6(6):R647-R55.

14. Ough M, Lewis A, Zhang Y, et al. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res. 2004 Nov;38(11):1223-33.

15. Manju V, Balasubramanian V, Nalini N. Oxidative stress and tumor markers in cervical cancer patients. J Biochem Mol Biol Biophys. 2002 Dec;6(6):387-90.

16. Lund-Olesen K. Etiology of multiple sclerosis: role of superoxide dismutase. Med Hypotheses. 2000 Feb;54(2):321-2.

17. Choi J, Rees HD, Weintraub ST, et al. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem. 2005 Mar 25;280(12):11648-55.

18. Hattori N. Etiology and pathogenesis of Parkinson’s disease: from mitochondrial dysfunctions to familial Parkinson’s disease. Rinsho Shinkeigaku. 2004 Apr;44(4-5):241-62.

19. Ueda K, Ogata M. Levels of erythrocyte superoxide dismutase activity in Japanese people. Acta Med Okayama. 1978 Dec;32(6):393-7.

20. Cutler RG. Antioxidants and longevity of mammalian species. Basic Life Sci. 1985;35:15-73.

21. Cutler RG. Antioxidants and aging. Am J Clin Nutr. 1991 Jan;53(1 Suppl):373S-9S.

22. Life Extension-sponsored study #1. Changes in serum levels of superoxide dismutase and catalase in humans after dietary SODzyme™ supplementation.

23. Bauerova K, Bezek A. Role of reactive oxygen and nitrogen species in etiopathologenesis of rheumatoid arthritis. Gen Physiol Biophys. 1999 Oct;18 Spec No:15-20.

24. Hadjigogos K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med. 2003 Mar;45(1):7-13.

25. Life Extension-sponsored study #2. Effects of oral SODzyme™ administration on pain scores in human subjects with arthritis.

26. Bijlsma JW, van de Putte LB. Non-steroidal anti-inflammatory agents (NSAID’s) with lesser side effects by selective inhibition of cyclo-oxygenase-2. Ned Tijdschr Geneeskd. 1998 Aug 1;142(31):1762-5.

27. Bjarnason I, Zanelli G, Smith T, et al. The pathogenesis and consequence of non-steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol Suppl. 1987;64:55-62.

28. Lazzaroni M, Bianchi PG. Gastrointestinal side effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment Pharmacol Ther. 2004 Jul;20 Suppl 248-58.

29. Beaugerie L, Thiefin G. Gastrointestinal complications related to NSAIDs. Gastroenterol Clin Biol. 2004 Apr;28 Spec No 3C62-C72.

30. Rudic RD, Brinster D, Cheng Y, et al. COX-2 derived prostacyclin modulates vascular remodeling. Circ Res. 2005 May 19.

31. Evensen S, Spigset O, Slordal L. COX-2 inhibitors—one step forward and two steps back. Tidsskr Nor Laegeforen. 2005 Apr 7;125(7):875-8.

32. Meier P, Meyer zu SA, Burnier M. Selective COX-2 inhibitors and cardiovascular risk. Rev Med Suisse. 2005 Feb 23;1(8):543-50.

33. Vouldoukis I, Conti M, Krauss P, et al. Supplementation with gliadin-combined plant superoxide dismutase extract promotes antioxidant defences and protects against oxidative stress. Phytother Res. 2004 Dec;18(12):957-62.

34. Vouldoukis I, Lacan D, Kamate C, et al. Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity. J Ethnopharmacol. 2004 Sep;94(1):67-75.

35. Flohe L. Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes. Mol Cell Biochem. 1988 Dec;84(2):123-31.

36. Muth CM, Glenz Y, Klaus M, et al. Influence of an orally effective SOD on hyperbaric oxygen-related cell damage. Free Radic Res. 2004 Sep;38(9):927-32.

37. Dolegowska B, Chlubek D. Isoprostanes—new possibility of the oxidative stress estimation. Przegl Lek. 2004;61(12):1410-4.

38.Caruso C, Lio D, Cavallone L, Francheschi C. Aging, longevity, inflammation, and cancer. Ann NY Acad Sci. 2004 Dec;1028:1-13.

39. Kortekangas P, Peltola O, Toivanen A, Aro HT. Synovial fliud L-lactic acid in acute arthritis of the adult knee joint. Scand J Rheumatol. 1995;24(2):98-101.

40. Kong Y, et al. korea Cancer Center Hospital. (2004) Influence of an orally effective superoxide dismutase (GliSODin®) on strenuous exercise-induced changes of blood antioxidant enzymes and plasma lactate. Poster presentation at the AACC, July 2004.

41. Chenal H, Davit-Spraul A, Legrand J, et al. Restored antioxidant circulating capacities in west African AIDS patients receiving an antioxidant nutraceutical Cucumis melo extract rich in Superoxide dismutase activity (GliSODin®). [Submitted for publication.]